‘Damning’ Information About Trans Medical Group Expected To Reach Supreme Court, as Justices Consider Challenge to Ban on Gender Treatments for Minors
🧵⬇️I report for the @NewYorkSun: Unsealed internal communications from the trans medical organization @WPATH will likely undermine pediatric gender-transition treatment in litigation, including a Supreme Court case.
‘Damning’ Information About Trans Medical Group Expected To Reach Supreme Court, as Justices Consider Challenge to Ban on Gender Treatments for Minors nysun.com/article/damnin…
The World Professional Association for Transgender Health is tasked with promoting and defending access to gender-transition treatment for minors. Amid a storm of litigation over these practices @WPATH’s leaders now find that their own words threaten to undermine this mission.
Last month, a federal court began unsealing an abundance of subpoenaed internal communications among top @WPATH members. The docs concern Wpath’s recent revision of the chapters in its trans-medical-care guidelines concerning pediatrics, or medical care for children and teens.
Wpath’s once-secret maneuverings, now laid bare, have only just begun to backfire. The explosive contents of the unsealed communications are expected to impact the litigation that will determine the future of pediatric gender medicine , including a SCOTUS ruling next term.
Erica Anderson, a psychologist, transgender woman, and former head of Wpath’s American branch, characterized the recent disclosures as “damaging” to @WPATH. @eanderh nysun.com/article/damnin…
Why did @WPATH remove all the age limits on pediatric gender-transition treatment in its 2022 revision on its treatment guidelines? Internal comms unsealed in an AL court case suggest HHS official Rachel Levine, the @AmerAcadPeds and @Trevor_Project all pressured WPATH to do so.
Even as she pressured @WPATH to remove age limits on pediatric gender-transition treatment for political reasons, Rachel Levine touted WPATH as the go-to source for evidence-based guide to such care and said that laws banning such treatment were all politically based.
WPATH published its new transgender treatment guidelines on Sept. 10, 2022, and later that same day removed the age limits on pediatric gender-transition treatment. This was in the immediate wake of the @AmerAcadPeds and the @Trevor_Project pressuring them to do so.
The documents unsealed in the Alabama court case that have so damaged @WPATH's credibility as a science-based organization removed from politics have already started to show up in litigation. nysun.com/article/damnin…
In private, at least some @WPATH members have acknowledged that the evidence behind some of their treatment recommendations is wanting. But in public the organization has said the opposite. nysun.com/article/damnin…
Eli Coleman, who headed up @WPATH's revision of its treatment guidelines, issued a full-throated denial of the suggestions of a trove of internal communications from the organization that were recently unsealed. nysun.com/article/damnin…
How might the unsealed @WPATH communications impact the Supreme Court case about Tennessee's pediatric gender-transition ban next term? I spoke with TN's attorney general, Jonathan Skrmetti, for the @NewYorkSun: nysun.com/article/damnin…
The internal @WPATH documents are also expected to aid the plaintiffs in the approximately 20 medical-malpractice lawsuits waged by detransitioners against their former care providers.
The unsealed @WPATH communications are expected to aid in the conspiracy suit against the @AmerAcadPeds. One WPATH member was particularly scornful of the AAP's 2018 policy statement on the gender-affirming care method. nysun.com/article/damnin…
Roger Brooks of the Alliance Defending Freedom said he expected the Alabama documents would have an even greater impact on future detransitioner lawsuits, by undermining physicians’ arguments that they were acting in good faith by following WPATH’s guidelines.
Psychologist Erica Anderson, who positioned herself as WPATH’s Cassandra some years ago, having sought to warn her colleagues that they were steering the organization in a perilous direction, reflected over what it has meant to have, as she sees it, been proved right.
“Many who know of my historic efforts to stem the tide of ideology have proclaimed that I should feel vindicated, but I cannot be consoled,” Dr. Anderson said.
The internal @WPATH communications in the Alabama suit over the state's pediatric gender-transition treatment ban also suggested that WPATH coordinated on the drafting of its 2022 trans-care guidelines update with the @ACLU, which is behind many of the lawsuits seeking to overturn the bans of the treatment that WPATH recommended in those guidelines. nysun.com/article/damnin…
Debunking podcaster Michael Hobbes has a new episode of his podcast If Books Could Kill, about the US v. Skrmetti Supreme Court decision upholding Tennessee's ban on pediatric gender-transition treatment.
Michael Hobbes, referring to a video, published in 2022 by @MattWalshBlog, of a Vanderbilt doctor talking about the money that gender-transition surgeries bring in, including bottom surgeries: “Bottom surgeries are essentially not performed on children," Hobbes says. "So the fact that she's talking about bottom surgeries here makes it very clear that she's talking about adults.”
This depends on your definition of "essentially." Phallopasties are not recommended by @WPATH for minors, but vaginoplasties are. Dr. Marci Bowers, a gender-affirming surgeon and a former WPATH president, recommends that trans girls get a vaginoplasty the summer before they leave for college, when they are 17 or 18.
A 2023 paper on a limited dataset of US minor patients did find evidence of one vaginoplasty in 2021. This suggests that if the study authors had access to all records in the nation, they would identify more such surgeries in minors.
Consequently, Hobbes is incorrect to presume that the Vanderbilt doctor was not referring to minors in the speech that Walsh published. It is entirely possible she was.
If, for the sake of argument, no one can prove that pediatric gender-transition treatment prevents suicide death only because such deaths are so rare, then why has this treatment been sold, first and foremost, as “lifesaving”?
Why have people who have called that claim into question been savagely attacked and sidelined?
Marci Bowers, former head of WPATH, herself told me last year that suicide death has never been a good metric of the success of this treatment.
Debunking podcaster Michael Hobbes is himself one of the prime sources of misinformation about pediatric gender-transition treatment. He has routinely falsely claimed that there is no evidence that children get these drugs after absent or cursory assessment periods. There is copious evidence that this happens routinely at some of the top gender clinics in the nation. Despite all this evidence, Hobbes has never acknowledged his fault.
But you can see here that he is combining his longstanding claim about assessments with a claim about what he characterizes as false claims that there are large numbers of kids getting these drugs. That question should not necessarily be conflated with the assessment question.
About 1 in 1,000 youth with private health insurance went on cross sex hormones by age 17 between 2018 and 2022. That number was higher for natal girls and was probably higher for all youth by the end of that period.
One thing that has concerned some people is not necessarily the number of kids getting these drugs, but the rate of increase of that number. They have been concerned over where that figure might end up.
If suicide deaths are so rare even in youth with gender dysphoria, then why have leading gender clinicians routinely told parents that absent blockers and hormones, their child was extremely likely to wind up dead? That’s what the mantra “Would you rather have a dead son or a live daughter?” implies. We now know from the leading litigator in this field that that threat was a false one, at the very least in the suggestion of how likely suicide death was in the first place.
Debunking podcaster Michael Hobbes, a prime source of misinformation about pediatric gender-transition treatment, slams @HelenLewis of @TheAtlantic for criticizing people such as him.
Ten years ago Thursday, the movement for gay and lesbian equality scored a victory that only a decade before had seemed unimaginable. We won equal rights to civil marriage in every state in the country. In 2020 came another stunning win. In a majority opinion written by one of President Trump’s nominees, Justice Neil Gorsuch, the Supreme Court found that gay men, lesbians and transgender men and women are covered under Title VII of the 1964 Civil Rights Act, and protected from employer discrimination.
In 2024, the Republican Party removed opposition to marriage equality from its platform, and the current Republican Treasury secretary, Scott Bessent, is a married gay man with two children. Gay marriage is backed by around 70 percent of Americans, and discrimination against gay men, lesbians and transgender people is opposed by 80 percent. As civil rights victories go, it doesn’t get more decisive or comprehensive than this.
Debunking podcaster Michael Hobbes has issued a stream of false or misleading claims about the Times article about the @ACLU’s tangled path to Skrmetti—the SCOTUS case on pediatric gender-transition treatment.
Allow me to demonstrate how wrong Hobbes is.
🧵⬇️
The thing about conspiracies is that sometimes they actually occur. Subpoenaed records show WPATH squelched systematic reviews of gender care they commissioned when the results did not support their advocacy movement.
And Hobbes, perhaps because he doesn’t know or understand what those reviews are about, issues a sleight of hand by suggesting that the reviews were irrelevant since there is no evidence kids are getting rushed into surgeries. But that’s not what the reviews were about. They were about the strength of the evidence backing gender-transition treatments.
One of Hobbes’ methods is he believes that all the supposedly bad-faith actors he scrutinizes work out of a common playbook.
The subpoenaed records show that WPATH leaders went well beyond trying to keep their work from being weaponized. They coordinated with Chase Strangio and others at the ACLU to draft their trans-care guidelines for the purpose of helping them win lawsuits, even as WPATH leaders themselves were already directly involved in such suits. And absent scientific justification, they included words like “medically necessary” in the guidelines for the purpose of securing insurance coverage.
But in Hobbes’ telling, the only bad-faith actor in this story is the Alabama attorney general for uncovering these records that revealed these actions on WPATH’s part.
This raises the question: Should those who create medical guidelines be transparent and remain honest with doctors and the public about the ways that the science is lacking?